|
|
Vaccine Detail
|
Infanrix -IPV/Hib |
| Vaccine Information |
- Vaccine Name: Infanrix -IPV/Hib
- Target Pathogen: Haemophilus influenzae
- Target Disease: Meningitis
- Product Name: Diphtheria, tetanus, pertussis (acellular component), poliomyelitis (inactivated) and Haemophilus type b conjugate vaccine (adsorbed)
- Tradename: Infanrix -IPV/Hib
- Manufacturer: GlaxoSmithKline
- Vaccine Ontology ID: VO_0010722
- CDC CVX code: 120
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- Preservative: 2 phenoxy ethanol
- Allergen: Polymyxin B Neomycin , Latex in plunger stopper of prefilled syringe
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store in a refrigerator (2°C – 8°C).
- Approved Age for Licensed Use: 2 months to 6 years of age.
- Description: Products: Proteins + killed virus + conjugate. Other components: Formaldehyde Polysorbate 80, Lactose.
|
| Host Response |
|
|
| References |
|
|
|
